Market Overview

Credit Suisse Reiterates Outperform on Mead Johnson Nutrition Following Management Meetings in China

Related MJN
Zimmer Posts Q2 Earnings Beat, Revenues Miss; Guides Low
Boston Scientific Tops Q2 Earnings, Revenues; Ups EPS View

In a report published Thursday, Credit Suisse analyst Robert Moskow reiterated an Outperform rating and $90.00 price target on Mead Johnson Nutrition Co. (NYSE: MJN).

In the report, Credit Suisse noted, “We recently attended meetings in China with Mead management. While the company is still struggling to get its arms around the volatility in the Chinese market, we continue to believe that there is some upside to consensus estimates owing to share gains from the temporary recall of competitors Danone and Abbott. This ‘gift' along with the easy comparisons to last year's missteps will give the stock some cover over the next two quarters while the Chinese market stabilizes.”

Mead Johnson Nutrition Co. closed on Wednesday at $74.25.

Latest Ratings for MJN

DateFirmActionFromTo
Jul 2014CitigroupMaintainsBuy
Jul 2014Credit SuisseMaintainsOutperform
Jul 2014Deutsche BankMaintainsBuy

View More Analyst Ratings for MJN
View the Latest Analyst Ratings

Posted-In: Credit Suisse Robert MoskowAnalyst Color Reiteration Analyst Ratings

 

Related Articles (MJN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters